Page last updated: 2024-12-05

dodecylmercaptan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dodecylmercaptan: used in polymerization of neoprenes; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8195
CHEMBL ID3185403
SCHEMBL ID15369
MeSH IDM0062173

Synonyms (84)

Synonym
LS-14165
1-dodecanethiol, antimony(3+) salt
nsc-11884
wln: 12s-sb-s12&s12
thioantimonic acid (h3sbs3), tridodecyl ester
stibine, tris(dodecylthio)-
6939-83-9
nsc11884
inchi=1/c12h26s/c1-2-3-4-5-6-7-8-9-10-11-12-13/h13h,2-12h2,1h
ccris 743
dodecyl mercaptan (van)
brn 0969337
hsdb 1074
einecs 203-984-1
nsc 814
nci-c60935
lauryl mercaptide
pennfloat s
dodecylmercaptan
ai3-07577
m-dodecyl mercaptan
pennfloat m
m-lauryl mercaptan
n-dodecyl mercaptan
nsc814
n-lauryl mercaptan
1-dodecanethiol
nsc-814
dodecyl mercaptan
dodecane-1-thiol
n-dodecanethiol
1-dodecyl mercaptan
1-mercaptododecane
112-55-0
lauryl mercaptan
1-dodecanethiol, >=98%
30237-11-7
nsc-229570
nsc229570
n-dodecylmercaptan
D0970
FT-0694976
FT-0693266
NCGC00249113-01
dodecanethiol
ec 203-984-1
s8zjb6x253 ,
unii-s8zjb6x253
dtxcid505220
cas-112-55-0
dtxsid6025220 ,
tox21_303101
NCGC00257179-01
tox21_201758
NCGC00259307-01
1322-36-7
AKOS015960383
BP-10739
FT-0607709
SCHEMBL15369
fema no. 4581
1-dodecylthiol
1-dodecanethiol [hsdb]
thiokalcol 20
J-504580
normal dodecylmercaptan
n-dodecylthiol
dodecane thiol
dodecyl-mercaptan
1-dodecanthiol
dodecanthiol
n-dodecyl-mercaptan
laurylmercaptan
dodecylthiol
1-dodecane thiol
normal dodecyl mercaptan
1-dodecylmercaptan
dodecanethiol-(1)
CHEMBL3185403
mfcd00004885
STL483072
1-dodecanethiol, purum, >=97.0% (gc)
Q161619
EN300-1859909

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" All the results suggest that HM-polysaccharide micellar systems have the potential of enhancing the bioavailability of poorly adsorbed drugs in peroral delivery."( In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems.
Chayed, S; Winnik, FM, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency61.41863.189029.884159.4836AID1224846
GLI family zinc finger 3Homo sapiens (human)Potency15.29290.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.26110.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.42500.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency60.88200.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.77320.000229.305416,493.5996AID743069; AID743078
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency24.54120.001024.504861.6448AID743215
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency18.52260.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.85)18.7374
1990's2 (3.70)18.2507
2000's25 (46.30)29.6817
2010's25 (46.30)24.3611
2020's1 (1.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.99 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index60.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]